Nippon India Pharma Fund-Growth Plan-Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 516.9486 ↑ 0.62%
[as on 20 October, 2025]

NAV chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Nippon India Pharma Fund-Growth Plan-Growth Option -2.35% 0.62% 0.77% -1.31% -1.14% -1.17% 22.23% 17.83% 18.93% 12.72%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.44% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.56%

Equity

NameSectorWeight %
Sun Pharmaceutical Industries LimitedPharmaceuticals & Biotechnology12.29%
Lupin LimitedPharmaceuticals & Biotechnology7.26%
Divi's Laboratories LimitedPharmaceuticals & Biotechnology7.01%
Cipla LimitedPharmaceuticals & Biotechnology6.48%
Apollo Hospitals Enterprise LimitedHealthcare Services5.92%
Dr. Reddy's Laboratories LimitedPharmaceuticals & Biotechnology5.91%
Vijaya Diagnostic Centre LimitedHealthcare Services3.56%
MedPlus Health Services LimitedRetailing3.39%
Gland Pharma LimitedPharmaceuticals & Biotechnology3.24%
GlaxoSmithKline Pharmaceuticals LimitedPharmaceuticals & Biotechnology2.99%
Ajanta Pharma LimitedPharmaceuticals & Biotechnology2.85%
Sai Life Sciences LimitedPharmaceuticals & Biotechnology2.71%
Abbott India LimitedPharmaceuticals & Biotechnology2.48%
Dr. Lal Path Labs LimitedHealthcare Services2.34%
Aurobindo Pharma LimitedPharmaceuticals & Biotechnology2.27%
Mankind Pharma LimitedPharmaceuticals & Biotechnology2.27%
Thyrocare Technologies LimitedHealthcare Services2.25%
Narayana Hrudayalaya LimitedHealthcare Services2.20%
Alkem Laboratories LimitedPharmaceuticals & Biotechnology2.16%
JB Chemicals & Pharmaceuticals LimitedPharmaceuticals & Biotechnology2.11%
Biocon LimitedPharmaceuticals & Biotechnology1.98%
Pfizer LimitedPharmaceuticals & Biotechnology1.98%
Suraksha Diagnostic LimitedHealthcare Services1.43%
IPCA Laboratories LimitedPharmaceuticals & Biotechnology1.35%
Torrent Pharmaceuticals LimitedPharmaceuticals & Biotechnology1.35%
Sanofi India LimitedPharmaceuticals & Biotechnology1.32%
Fortis Healthcare LimitedHealthcare Services1.32%
Sanofi Consumer Healthcare India LimitedPharmaceuticals & Biotechnology1.24%
Anthem Biosciences LimitedPharmaceuticals & Biotechnology0.99%
Syngene International LimitedHealthcare Services0.98%
Akums Drugs and Pharmaceuticals LimitedPharmaceuticals & Biotechnology0.82%
Emcure Pharmaceuticals LimitedPharmaceuticals & Biotechnology0.74%
AstraZeneca Pharma India LimitedPharmaceuticals & Biotechnology0.70%
Indoco Remedies LimitedPharmaceuticals & Biotechnology0.66%
Orchid Pharma LimitedPharmaceuticals & Biotechnology0.43%
Zydus Lifesciences LimitedPharmaceuticals & Biotechnology0.23%
Concord Biotech LimitedPharmaceuticals & Biotechnology0.23%
Portfolio data is as on date 30 September, 2025

NAV (Net asset value) history

Nippon India Pharma Fund-Growth Plan-Growth Option - 30 days NAV history

DateNAV
20 October, 2025516.9486
17 October, 2025513.7513
16 October, 2025512.7548
15 October, 2025510.1467
14 October, 2025510.0573
13 October, 2025512.9990
10 October, 2025512.5452
9 October, 2025507.3514
8 October, 2025503.7065
7 October, 2025506.1949
6 October, 2025504.8811
3 October, 2025502.7267
1 October, 2025501.1883
30 September, 2025495.9891
29 September, 2025497.7328
26 September, 2025498.1117
25 September, 2025508.1333
24 September, 2025512.2475
23 September, 2025515.5090
22 September, 2025517.5503
19 September, 2025523.7962
18 September, 2025521.6163
17 September, 2025518.4455
16 September, 2025518.1239
15 September, 2025516.9879
12 September, 2025518.8848
11 September, 2025517.0466
10 September, 2025515.2597
9 September, 2025513.3902
8 September, 2025511.9972

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The latest NAV of Nippon India Pharma Fund-Growth Plan-Growth Option is 516.9486 as on 20 October, 2025.
  • What are YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option are -2.35% as on 20 October, 2025.
  • What are 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option are -1.17% as on 20 October, 2025.
  • What are 3 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 3 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 22.23% as on 20 October, 2025.
  • What are 5 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 5 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 17.83% as on 20 October, 2025.
  • What are 10 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 10 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 17.83% as on 20 October, 2025.